— sNDA filing acceptance is based on positive data from the Phase 3 ADORING 1 and ADORING 2 pivotal trials and interim results from the Phase 3 ADORING 3 open-label, long-term extension trial — — FDA PDUFA Action Expected in Q4 2024 — LONG BEACH, Calif., and BASEL, Switzerland, April 29, 2024 – Dermavant Sciences, […]
Search Results for: VTAMA® (tapinarof) cream, 1%